Filing Details
- Accession Number:
- 0001127602-12-030974
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-15 16:30:34
- Reporting Period:
- 2012-11-13
- Filing Date:
- 2012-11-15
- Accepted Time:
- 2012-11-15 16:30:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
946840 | Viropharma Inc | VPHM | Pharmaceutical Preparations (2834) | 232789550 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1273313 | Md D William Claypool | 730 Stockton Drive Exton PA 19341 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-11-13 | 10,000 | $9.15 | 64,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-11-13 | 10,000 | $24.84 | 54,500 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-11-13 | 12,500 | $5.68 | 67,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-11-13 | 12,500 | $25.01 | 54,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2012-11-13 | 10,000 | $0.00 | 10,000 | $9.15 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2012-11-13 | 12,500 | $0.00 | 12,500 | $5.68 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-02-25 | 2018-02-25 | No | 4 | M | Direct |
2,500 | 2010-02-23 | 2019-02-22 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $24.74 to $24.88, inclusive.
- The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.05, inclusive.
- The options vest in full one year from date of grant.